rheumatology
Medicines

De-listing of paracetamol ‘premature’: Arthritis Australia

The removal of sustained release paracetamol from the PBS is premature, especially in the absence of health system support for more effective alternatives to help people manage their arthritis pain, Arthritis Australia says. In a written statement published on Friday the organisation also reiterated its concern that the removal of the 665mg ‘osteo’ slow release formulation ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic